This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

27 Sep 2010

Amgen’s Biomarker Research Underlies Vectibix’ Success

An additional approval for Vectibix in head and neck cancer would have significantly expanded the market for the drug.

Related News